Published in Value Health on January 15, 2010
Assessing personalized medicines in Australia: a national framework for reviewing codependent technologies. Med Decis Making (2012) 1.15
Do economic evaluations of targeted therapy provide support for decision makers? Am J Manag Care (2011) 0.81
Do economic evaluations of targeted therapy provide support for decision makers? J Oncol Pract (2011) 0.78
Micrometastases or isolated tumor cells and the outcome of breast cancer. N Engl J Med (2009) 5.36
MRI with a lymph-node-specific contrast agent as an alternative to CT scan and lymph-node dissection in patients with prostate cancer: a prospective multicohort study. Lancet Oncol (2008) 2.76
Multicenter validation of a gene expression-based prognostic signature in lymph node-negative primary breast cancer. J Clin Oncol (2006) 2.48
Integrated multidisciplinary diagnostic approach for dementia care: randomised controlled trial. Br J Psychiatry (2008) 2.45
Specialised treatment based on cognitive behaviour therapy versus usual care for tinnitus: a randomised controlled trial. Lancet (2012) 2.41
Self-measurement of blood pressure at home reduces the need for antihypertensive drugs: a randomized, controlled trial. Hypertension (2007) 2.33
Comparison of the effectiveness of radiotherapy with photons, protons and carbon-ions for non-small cell lung cancer: a meta-analysis. Radiother Oncol (2009) 2.21
Safely ruling out deep venous thrombosis in primary care. Ann Intern Med (2009) 2.16
Healthy decisions: towards uncertainty tolerance in healthcare policy. Pharmacoeconomics (2015) 2.01
Methodological quality of economic evaluations of new pharmaceuticals in The Netherlands. Pharmacoeconomics (2012) 1.79
Vascular endothelial growth factor is associated with the efficacy of endocrine therapy in patients with advanced breast carcinoma. Cancer (2003) 1.74
Utilities of the EQ-5D: transferable or not? Pharmacoeconomics (2009) 1.74
What do international pharmacoeconomic guidelines say about economic data transferability? Value Health (2010) 1.74
Are breast conservation and mastectomy equally effective in the treatment of young women with early breast cancer? Long-term results of a population-based cohort of 1,451 patients aged ≤ 40 years. Breast Cancer Res Treat (2010) 1.73
Tissue inhibitors of metalloproteinase expression in human breast cancer: TIMP-3 is associated with adjuvant endocrine therapy success. J Pathol (2004) 1.67
Cost-effectiveness analysis of sacral neuromodulation and botulinum toxin A treatment for patients with idiopathic overactive bladder. BJU Int (2010) 1.60
Modeling the 5-year cost effectiveness of treatment strategies including tumor necrosis factor-blocking agents and leflunomide for treating rheumatoid arthritis in the Netherlands. Arthritis Rheum (2004) 1.55
Safety of avoiding routine use of axillary dissection in early stage breast cancer: a systematic review. Breast Cancer Res Treat (2010) 1.53
Does fast-track treatment lead to a decrease of intensive care unit and hospital length of stay in coronary artery bypass patients? A meta-regression of randomized clinical trials. Crit Care Med (2006) 1.49
Short-stay intensive care after coronary artery bypass surgery: randomized clinical trial on safety and cost-effectiveness. Crit Care Med (2006) 1.44
The burden of illness of rheumatoid arthritis. Clin Rheumatol (2011) 1.43
Process evaluation of a multifaceted intervention to improve cardiovascular disease prevention in general practice. Eur J Gen Pract (2003) 1.43
Cost-effectiveness of ablation surgery in patients with atrial fibrillation undergoing cardiac surgery. Interact Cardiovasc Thorac Surg (2010) 1.42
Signalling pathways in vasculogenic mimicry. Biochim Biophys Acta (2010) 1.38
Survivin is an independent prognostic marker for risk stratification of breast cancer patients. Clin Chem (2004) 1.36
Healthcare financing systems for increasing the use of tobacco dependence treatment. Cochrane Database Syst Rev (2009) 1.30
Joint recovery programme versus usual care: an economic evaluation of a clinical pathway for joint replacement surgery. Med Care (2005) 1.25
Impact of breast surgery on survival in patients with distant metastases at initial presentation: a systematic review of the literature. Breast Cancer Res Treat (2009) 1.25
Cost-effectiveness of adding granulocyte colony-stimulating factor to primary prophylaxis with antibiotics in small-cell lung cancer. J Clin Oncol (2006) 1.24
The methodological quality of economic evaluations of guideline implementation into clinical practice: a systematic review of empiric studies. Value Health (2007) 1.23
Improving management of patients with acute cough by C-reactive protein point of care testing and communication training (IMPAC3T): study protocol of a cluster randomised controlled trial. BMC Fam Pract (2007) 1.22
Involving patients in cardiovascular risk management with nurse-led clinics: a cluster randomized controlled trial. CMAJ (2009) 1.16
How costly is particle therapy? Cost analysis of external beam radiotherapy with carbon-ions, protons and photons. Radiother Oncol (2010) 1.15
Performance of the EQ-5D and the EQ-5D+C in elderly patients with cognitive impairments. Health Qual Life Outcomes (2007) 1.14
Cost-effectiveness of the 70-gene signature versus St. Gallen guidelines and Adjuvant Online for early breast cancer. Eur J Cancer (2010) 1.12
Impact of ankylosing spondylitis on sick leave, presenteeism and unpaid productivity, and estimation of the societal cost. Ann Rheum Dis (2010) 1.11
Prognostic relevance of uPAR-del4/5 and TIMP-3 mRNA expression levels in breast cancer. Eur J Cancer (2005) 1.10
Correcting for compensating mechanisms related to productivity costs in economic evaluations of health care programmes. Health Econ (2005) 1.10
Cyclin-E is a strong predictor of endocrine therapy failure in human breast cancer. Oncogene (2003) 1.08
The cost-effectiveness of particle therapy in non-small cell lung cancer: exploring decision uncertainty and areas for future research. Cancer Treat Rev (2010) 1.08
Out-patient psychotherapy for borderline personality disorder: cost-effectiveness of schema-focused therapy v. transference-focused psychotherapy. Br J Psychiatry (2008) 1.08
Non-sentinel lymph node metastases associated with isolated breast cancer cells in the sentinel node. J Natl Cancer Inst (2008) 1.07
Does a joint development and dissemination of multidisciplinary guidelines improve prescribing behaviour: a pre/post study with concurrent control group and a randomised trial. BMC Health Serv Res (2006) 1.06
Health-related quality of life in patients surviving non-small cell lung cancer. Thorax (2010) 1.05
Prognosis of metastatic breast cancer subtypes: the hormone receptor/HER2-positive subtype is associated with the most favorable outcome. Breast Cancer Res Treat (2013) 1.04
The relationship between productivity and health-related QOL: an exploration. Pharmacoeconomics (2005) 1.04
When to wait for more evidence? Real options analysis in proton therapy. Oncologist (2011) 1.02
Vitalum study design: RCT evaluating the efficacy of tailored print communication and telephone motivational interviewing on multiple health behaviors. BMC Public Health (2008) 1.02
Economic evaluations of healthcare programmes and decision making: the influence of economic evaluations on different healthcare decision-making levels. Pharmacoeconomics (2005) 1.01
Accuracy of sentinel node biopsy after neoadjuvant chemotherapy in breast cancer patients: a systematic review. Eur J Cancer (2009) 1.01
The Maastricht Ultrasound Shoulder pain trial (MUST): ultrasound imaging as a diagnostic triage tool to improve management of patients with non-chronic shoulder pain in primary care. BMC Musculoskelet Disord (2011) 1.00
Cost-effectiveness acceptability curves and a reluctance to lose. Pharmacoeconomics (2005) 1.00
Cost-effectiveness of seven IVF strategies: results of a Markov decision-analytic model. Hum Reprod (2009) 0.99
Choosing between measures: comparison of EQ-5D, HUI2 and HUI3 in persons with hearing complaints. Qual Life Res (2007) 0.99
Willingness to accept versus willingness to pay in a discrete choice experiment. Value Health (2008) 0.98
Tinnitus: a cost study. Ear Hear (2013) 0.96
Regional recurrence in breast cancer patients with sentinel node micrometastases and isolated tumor cells. Ann Surg (2012) 0.96
ADAMTS8 and ADAMTS15 expression predicts survival in human breast carcinoma. Int J Cancer (2006) 0.95
The transferability of valuing lost productivity across jurisdictions. differences between national pharmacoeconomic guidelines. Value Health (2010) 0.93
Productivity cost calculations in health economic evaluations: correcting for compensation mechanisms and multiplier effects. Soc Sci Med (2012) 0.93
The long term effectiveness and cost-effectiveness of initiating treatment for ocular hypertension. Acta Ophthalmol (2013) 0.92
Economic evaluation of an integrated diagnostic approach for psychogeriatric patients: results of a randomized controlled trial. Arch Gen Psychiatry (2009) 0.92
Implementing cognitive behavior therapy for chronic fatigue syndrome in mental health care: a costs and outcomes analysis. BMC Health Serv Res (2008) 0.92
Acknowledging patient heterogeneity in economic evaluation : a systematic literature review. Pharmacoeconomics (2013) 0.92
Protons in head-and-neck cancer: bridging the gap of evidence. Int J Radiat Oncol Biol Phys (2012) 0.92
Development of a composite questionnaire, the valuation of lost productivity, to value productivity losses: application in rheumatoid arthritis. Value Health (2011) 0.92
Diagnostic and economic evaluation of new biomarkers for Alzheimer's disease: the research protocol of a prospective cohort study. BMC Neurol (2012) 0.92
Scenario drafting to anticipate future developments in technology assessment. BMC Res Notes (2012) 0.92
Cost effectiveness of adding dapagliflozin to insulin for the treatment of type 2 diabetes mellitus in the Netherlands. Clin Drug Investig (2014) 0.91
Risk factors for non-sentinel lymph node metastases in patients with breast cancer. The outcome of a multi-institutional study. Ann Surg Oncol (2006) 0.91
Quality of integrated care for patients with nonsmall cell lung cancer: variations and determinants of care. Cancer (2007) 0.91
Modeling the cost effectiveness of secondary febrile neutropenia prophylaxis during standard-dose chemotherapy. J Clin Oncol (2008) 0.90
Determinants of care costs of patients with dementia or cognitive impairment. Alzheimer Dis Assoc Disord (2013) 0.90
The impact of late treatment-toxicity on generic health-related quality of life in head and neck cancer patients after radiotherapy. Oral Oncol (2011) 0.90
Predictive factors for the objective burden of informal care in people with dementia: a systematic review. Alzheimer Dis Assoc Disord (2012) 0.90
Considered judgement in evidence-based guideline development. Int J Qual Health Care (2006) 0.90
Primary granulocyte colony-stimulating factor prophylaxis during the first two cycles only or throughout all chemotherapy cycles in patients with breast cancer at risk for febrile neutropenia. J Clin Oncol (2013) 0.89
Predictive impact of urokinase-type plasminogen activator: plasminogen activator inhibitor type-1 complex on the efficacy of adjuvant systemic therapy in primary breast cancer. Cancer Res (2004) 0.89
Cost-effectiveness of tailored print communication, telephone motivational interviewing, and a combination of the two: results of an economic evaluation alongside the Vitalum randomized controlled trial. Int J Behav Nutr Phys Act (2010) 0.89
The long-term outcomes of four alternative treatment strategies for primary open-angle glaucoma. Acta Ophthalmol (2012) 0.89
The relationship between productivity and health-related quality of life: an empirical exploration in persons with low back pain. Qual Life Res (2005) 0.89
Systematic review and meta-analysis of radiotherapy in various head and neck cancers: comparing photons, carbon-ions and protons. Cancer Treat Rev (2011) 0.89
Patient preferences for direct hearing aid provision by a private dispenser. A discrete choice experiment. Ear Hear (2008) 0.89
Implementing guidelines into clinical practice: what is the value? J Eval Clin Pract (2010) 0.88
Difficulties in calculating productivity costs: work disability associated with borderline personality disorder. Value Health (2007) 0.88
Considering early detection of relapsed ovarian cancer: a review of the literature. Int J Gynecol Cancer (2011) 0.88
Design and evaluation of a computer reminder system to improve prescribing behaviour of GPs. Stud Health Technol Inform (2006) 0.88
More is not always better: cost-effectiveness analysis of combined, single behavioral and single physical rehabilitation programs for chronic low back pain. Eur J Pain (2008) 0.88
Taxane resistance in breast cancer: a closed HER2 circuit? Biochim Biophys Acta (2012) 0.87
Cost effectiveness of an adherence-improving programme in hypertensive patients. Pharmacoeconomics (2007) 0.87
Cost-effectiveness of a nurse-led telemonitoring intervention based on peak expiratory flow measurements in asthmatics: results of a randomised controlled trial. Cost Eff Resour Alloc (2007) 0.87
Encouraging smokers to quit: the cost effectiveness of reimbursing the costs of smoking cessation treatment. Pharmacoeconomics (2006) 0.86